145 related articles for article (PubMed ID: 22368761)
21. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
[TBL] [Abstract][Full Text] [Related]
22. Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease.
Greenspan JS
Oral Dis; 1997 May; 3 Suppl 1():S13-7. PubMed ID: 9456650
[TBL] [Abstract][Full Text] [Related]
23. The burden of oral conditions among adolescents living with HIV at a clinic in Johannesburg, South Africa.
Malele Kolisa Y; Yengopal V; Shumba K; Igumbor J
PLoS One; 2019; 14(10):e0222568. PubMed ID: 31618211
[TBL] [Abstract][Full Text] [Related]
24. Oral manifestations of HIV infection by gender and transmission category in Mexico City.
Ramirez-Amador V; Esquivel-Pedraza L; Sierra-Madero J; Ponce-de-Leon S; Ponce-de-Leon S
J Oral Pathol Med; 1998 Mar; 27(3):135-40. PubMed ID: 9563806
[TBL] [Abstract][Full Text] [Related]
25. Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA.
Schneider G; Juday T; Wentworth C; Lanes S; Hebden T; Seekins D
AIDS Care; 2013; 25(11):1470-6. PubMed ID: 23517139
[TBL] [Abstract][Full Text] [Related]
26. Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali.
Sylla M; Dolo O; Maiga AI; Traore FT; Coulibaly YA; Togo J; Fofana DB; Dicko-Traore F; Doumbia S; Orsega S; Diallo S; Murphy RL; Calvez V; Marcelin AG
Arch Pediatr; 2019 Jul; 26(5):254-258. PubMed ID: 31307909
[TBL] [Abstract][Full Text] [Related]
27. Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions.
Lamster IB; Begg MD; Mitchell-Lewis D; Fine JB; Grbic JT; Todak GG; el-Sadr W; Gorman JM; Zambon JJ; Phelan JA
Oral Surg Oral Med Oral Pathol; 1994 Aug; 78(2):163-74. PubMed ID: 7936584
[TBL] [Abstract][Full Text] [Related]
28. Changes in nutritional, functional and immunological status of HIV-infected adults with antiretroviral therapy.
Tafese Z; Berhan Y; Abebe H
Ethiop Med J; 2012 Jan; 50(1):75-87. PubMed ID: 22519164
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
[TBL] [Abstract][Full Text] [Related]
30. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
Siegfried N; Uthman OA; Rutherford GW
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of HIV-Associated Oral Lesions in Relation to Early versus Delayed Antiretroviral Therapy: Results from the CIPRA HT001 Trial.
Batavia AS; Secours R; Espinosa P; Jean Juste MA; Severe P; Pape JW; Fitzgerald DW
PLoS One; 2016; 11(3):e0150656. PubMed ID: 26930571
[TBL] [Abstract][Full Text] [Related]
32. Oral manifestations after immune reconstitution in HIV patients on HAART.
Ortega KL; Ceballos-Salobreña A; Gaitán-Cepeda LA; Magalhães MG
Int J STD AIDS; 2008 May; 19(5):305-8. PubMed ID: 18482959
[TBL] [Abstract][Full Text] [Related]
33. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.
Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ
BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178
[TBL] [Abstract][Full Text] [Related]
35. Correlation of CD4 counts and CD4/CD8 ratio with HIV-infection associated oral manifestations.
Butt FM; Vaghela VP; Chindia ML
East Afr Med J; 2007 Aug; 84(8):383-8. PubMed ID: 17970007
[TBL] [Abstract][Full Text] [Related]
36. Intestinal parasitic infections in relation to CD4(+) T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in Cameroon.
Nsagha DS; Njunda AL; Assob NJC; Ayima CW; Tanue EA; Kibu OD; Kwenti TE
BMC Infect Dis; 2016 Jan; 16():9. PubMed ID: 26754404
[TBL] [Abstract][Full Text] [Related]
37. Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003-2013: TREAT Asia HIV Observational Database Low Intensity Transfer.
De La Mata NL; Ly PS; Ng OT; Nguyen KV; Merati TP; Pham TT; Lee MP; Choi JY; Sohn AH; Law MG; Kumarasamy N
Int J STD AIDS; 2017 Nov; 28(13):1282-1291. PubMed ID: 28632481
[TBL] [Abstract][Full Text] [Related]
38. Changing prevalence of human immunodeficiency virus-associated oral lesions.
Dios PD; Ocampo A; Miralles C; Limeres J; Tomás I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):403-4. PubMed ID: 11027372
[No Abstract] [Full Text] [Related]
39. Adverse drug reactions to antiretroviral therapy during the early art period at a tertiary hospital in Ghana.
Lartey M; Asante-Quashie A; Essel A; Kenu E; Ganu V; Neequaye A
Pan Afr Med J; 2014; 18():25. PubMed ID: 25368714
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of oral manifestations of HIV infection in Rio De Janeiro, Brazil from 1988 to 2004.
Ferreira S; Noce C; Júnior AS; Gonçalves L; Torres S; Meeks V; Luiz R; Dias E
AIDS Patient Care STDS; 2007 Oct; 21(10):724-31. PubMed ID: 17949271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
